Aksa Pharma SRL
1.6 FTEAksa Pharma reported total assets of 293,776 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026), with 1.6 full-time equivalent.
The score of Aksa Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -54 % Headcount (avg FTE) -47 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Aksa Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −220,750 € | ||||
| Equity | −64,128 € | ||||
| Cash | 3,901 € | ||||
| EBITDA | −176,372 € | ||||
| Total assets | 293,776 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 23 Jun 2026
- Year ended 31 Dec 2023filed on 01 Sep 2024
- Year ended 31 Dec 2022filed on 05 Sep 2023
- Year ended 31 Dec 2021filed on 14 Sep 2022
Aksa Pharma's financial analysis
- Solvency-21.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Aksa Pharma
Aksa Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0651.787.243
- VAT number
- BE0651787243
- Peppol
- Registered · 0208:0651787243 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Apr 2016
- Registered office
- 1020 Brussels
- Size
- Micro · 1.6 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Aksa Pharma (SRL) has been based in Brussels since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 220,750 € and equity of −64,128 €; its revenue is not published. With 1.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -21.8%, below the median of its sector (37.8%).
Companies similar to Aksa Pharma
Companies in the same business, of comparable size and area, outside its group.
- LES Iles D'OR Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 291,796 €
- Askela Retail sale of pharmaceutical products Chièvres · balance sheet 293,294 €
- Pharmacie Gendebien A Ninane Retail sale of pharmaceutical products Chaudfontaine · balance sheet 292,681 €
- Theunissen-DE Neve Retail sale of pharmaceutical products Aalst · balance sheet 291,003 €
- AONA Retail sale of pharmaceutical products Roeselare · balance sheet 290,456 €
- Leveugle Retail sale of pharmaceutical products Deinze · balance sheet 297,608 €
- ACE Pharma Retail sale of pharmaceutical products Fexhe-le-Haut-Clocher · balance sheet 289,661 €
- Warquigniespharma Retail sale of pharmaceutical products Colfontaine · balance sheet 299,659 €
Frequently asked questions about Aksa Pharma
What is the revenue of Aksa Pharma?
Aksa Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Aksa Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0651787243 for Aksa Pharma, if the company is VAT-registered. Its company number (CBE) is 0651.787.243.
Where is the registered office of Aksa Pharma?
According to the CBE register, the registered office of Aksa Pharma is in 1020 Brussels.
What is the equity of Aksa Pharma?
At the close of the 2025 financial year, the equity of Aksa Pharma amounts to -64,128 €, a solvency of -21.8% of total assets.
How many people work at Aksa Pharma?
1.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Aksa Pharma?
The register lists 1 active mandates at Aksa Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Aksa Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →